Navigation Links
New drug shows promise against multiple sclerosis
Date:11/1/2011

a remarkable finding," said Stephen Hauser, MD, the Robert A. Fishman Distinguished Professor and Chair of the Department of Neurology at UCSF who was the senior author on the study. "This is extremely exciting, both in terms of the prospect of improved therapy for people with multiple sclerosis but also for the lessons that it teaches us about the fundamental cause of the disease."

"The prospect of an extremely effective therapy for multiple sclerosis that can be safely administered at six month intervals could represent a major step forward, if the safety profile and benefits are sustained over longer periods of use," he added.

At 24 weeks, serious adverse events were reported in 4 percent of patients in the placebo arm, 4 percent of those taking interferon, and 2 percent and 6 percent of patients taking 600 mg and 2000 mg of Ocrelizumab. One patient taking Ocrelizumab died, but the relationship with the study drug, if any, is as yet unclear.

Hauser said that the next step for the drug will be to see if the drug's effect and positive safety profile will be sustained over time. These questions will be addressed in two parallel Phase 3 trials, now enrolling a larger number of patients who will receive the drug regimens for a longer period of time. This trial is now underway at several hundred sites around the world. Hauser serves as lead investigator for these trials, which are sponsored by Roche, the company that owns Ocrelizumab.

What the Trial Suggests About Multiple Sclerosis

Besides the obvious question of whether the drug would work, also under scrutiny in the clinical trial was whether a drug like Ocrelizumab would work in the first place. Its mechanism of action is fundamentally different than other existing therapies for multiple sclerosis. All multiple sclerosis drugs work by targeting a person's immune system only they target fundamentally different parts.

In multiple sclerosis, a person's im
'/>"/>

Contact: Jason Socrates Bardi
jason.bardi@ucsf.edu
415-502-4608
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Preterm birth rate shows three year improvement in most states
2. Study shows no increased risk of breast cancer for non-carriers in families with BRCA gene mutation
3. Novel approach to treat proliferative vitreoretinopathy shows promise
4. New therapy shows promise for treating cardiovascular disease
5. More Evidence Shows Newer Forms of Pill Raise Clot Risk, FDA Says
6. New oncolytic virus shows improved effectiveness in preclinical testing
7. Clinical trial shows first evidence that anal cancer is preventable
8. Through-the-nipple breast cancer therapy shows promise in early tests
9. Compound found in common wart treatment shows promise as leukemia therapy
10. Study shows why underrepresented men should be included in binge eating research
11. HIV Medication Patch Shows Promise in Early Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2015)... Chicago, IL (PRWEB) March 29, 2015 ... Foundation for Women’s Cancer announce today that ... 2015 recipient of the Claudia Cohen Research Foundation Prize ... presented at the Society of Gynecologic Oncology 46th Annual ... is Director of the Cedars-Sinai Women’s Cancer Program at ...
(Date:3/29/2015)... 2015 Final Cut Pro X ... Pixel Film Studios, entitled TranSports. , “TranSports is ... Final Cut Pro X,” said Christiana Austin, CEO of ... needed to effortlessly transition using this cool sports transition ... and uniquely styled transition pack for Final Cut Pro ...
(Date:3/28/2015)... Tucson, AZ. (PRWEB) March 28, 2015 ... according to a new study by researchers ... (HSPH). , Produced with the support of the Coffee ... the journal Molecular Psychiatry this past fall, the study—one ... a meta-analysis of genomic data from more than 120,000 ...
(Date:3/28/2015)... The California-based leading wig brand UniWigs ... shopping on UniWigs during the Easter Holidays from today ... promotion on April Fools’ Day. , As the winter ... the corner. Easter Festival, with religious origins to countries ... holiday after Christmas. The best wig provider, UniWigs, would ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 Pitching ... with a history of shoulder and elbow injuries, according to ... Sports Medicine’s ( AOSSM ) Specialty Day. , “Our findings ... with a 20% increase in likelihood of a history of ... associated with a 12% increase likelihood of a history of ...
Breaking Medicine News(10 mins):Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 2Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 3Health News:Dr. Beth Y. Karlan Named Recipient of the Claudia Cohen Research Foundation Prize for Outstanding Gynecologic Cancer Researcher 2015 4Health News:Introducing TranSports for Final Cut Pro X Users from Pixel Film Studios 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2
... ... parenting tips for teens , ... Washington, DC (Vocus) October 16, 2009 -- More than 30 pediatric experts from Children’s ... Conference and Exhibition, which runs from October 16 – 19 in Washington. , , , ...
... SAN ANTONIO, Oct. 16 The National Trauma Institute, ... in the United States, announced its first Request for ... to change medical practice and save lives. , The ... translational research to take place in 2010. "Historically, trauma ...
... Friday, October 16, U.S. President Barack Obama will join U.S. ... Texas to celebrate the 20th Anniversary of Points of Light ... in their communities. , The anniversary marks President Bush,s inauguration ... of Light" to salute and encourage individuals to solve problems ...
... Pa., Oct. 16 Amgen (Nasdaq: AMGN ) ... scientific data about ENBREL being presented at the 2009 ... Pa., from Oct. 17-21, 2009. These presentations contribute to ... , "The clinical data being presented at ...
... Rotary International has declared October 24, 2009, "World Polio Day" ... In the past 10 years alone Rotarians in Alaska and ... of a polio-free world. They have also traveled to places ... national immunization days. , In 1985, Rotary International joined with ...
... will allow public forum for discussing the latest updates, information on ... of the public are invited to submit questions for inclusion in ... Thursday, Oct. 22, from 10 a.m. - noon on Twitter. ... of Michigan Health System and VA Ann Arbor Healthcare System, will ...
Cached Medicine News:Health News:Children's National Experts Presenting at American Academy of Pediatrics Conference, 2Health News:National Trauma Institute Announces $600,000 in Funding for Trauma Research 2Health News:President Barack Obama Joins President George H.W. Bush to Celebrate the 20th Anniversary of the 'Points of Light' Volunteer Movement and Extend the Call of Service to the Nation 2Health News:President Barack Obama Joins President George H.W. Bush to Celebrate the 20th Anniversary of the 'Points of Light' Volunteer Movement and Extend the Call of Service to the Nation 3Health News:President Barack Obama Joins President George H.W. Bush to Celebrate the 20th Anniversary of the 'Points of Light' Volunteer Movement and Extend the Call of Service to the Nation 4Health News:President Barack Obama Joins President George H.W. Bush to Celebrate the 20th Anniversary of the 'Points of Light' Volunteer Movement and Extend the Call of Service to the Nation 5Health News:President Barack Obama Joins President George H.W. Bush to Celebrate the 20th Anniversary of the 'Points of Light' Volunteer Movement and Extend the Call of Service to the Nation 6Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 2Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 3Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 4Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 5Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 6Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 7Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 8Health News:Enbrel(R) (etanercept) Data to be Presented at the 2009 American College of Rheumatology Scientific Meeting 9
(Date:3/27/2015)... , March 27, 2015 ... International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare, ... senior service industry, will be held at Shanghai New ... On 25 February, 2015,  Implementation Suggestions on Encouraging Private ... Industry, which was jointly issued by the Ministry of ...
(Date:3/27/2015)... 2015 According to a new ... (Conventional, Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, Microwave), Lab ... VT, WPW) - Global Forecasts to 2019 ", published by ... around ~$4.73 Billion by 2019 with a CAGR of ... Browse   90   ma ...
(Date:3/27/2015)... DALLAS , March 27, 2015   ... global leader in biosimilars and the world,s leading ... two studies that support an evaluation of biosimilarity ... U.S. Food and Drug Administration (FDA) conditionally approved ... Amgen,s EPOGEN™ (epoetin alfa). These study data were ...
Breaking Medicine Technology:CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
... DIEGO, Oct. 19 Ceregene, Inc., a biopharmaceutical company, ... double-blind sham surgery-controlled Phase 2b study evaluating CERE-120 in ... that delivers the neurotrophic factor neurturin to degenerating or ... clinical trial of CERE-120 are being published later this ...
... PRGO ; TASE) today announced that it will release ... November 2, 2010 at approximately 8:00 a.m. (ET).  The Company ... by Joseph C. Papa, Perrigo,s Chairman and Chief Executive Officer. ... webcast to interested parties on the Perrigo website http://www.perrigo.com ...
Cached Medicine Technology:Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinson's Disease 2Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinson's Disease 3Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinson's Disease 4Ceregene Initiates a New Controlled Phase 2b Trial of CERE-120 for Parkinson's Disease 5
... gentle and effective surgical scrub with special ... is known to kill skin surface pathogens, ... protozoa and yeasts. It produces a rich ... pre-operative prepping, as well as for pre-and ...
... Aplicare two and four ounce ... meet the needs of procedural ... bottle itself has been custom ... match the cap perfectly. This ...
A patient skin prepping solution in a self-contained applicator combining two proven broad-spectrum antimicrobials: alcohol for fast kill and fast drying (3 minutes on skin), and an iodophor for pers...
Idophor PVP Scrub Winged Sponges...
Medicine Products: